ENhancing outcomes in Cognitive impairment through use of Home sleep ApNea Testing (ENCHANT)

What is the study about?

 

The purpose of the ENCHANT study is to determine whether screening for sleep apnea using a Home Sleep Apnea Test, compared to the current standard care using an in-laboratory sleep study, increases the number of patients with cognitive impairment diagnosed and treated for sleep apnea.

 

 

Eligibility- Who can participate?

Participants must be:

• diagnosed with cognitive impairment (e.g. Alzheimer’s disease, mild cognitive impairment, vascular dementia, vascular mild cognitive impairment, Parkinson’s disease-related dementia, etc.)
• Available to complete overnight sleep testing (at home or in-hospital), as well as clinical and follow-up assessments
• Not using a CPAP or dental appliance for Obstructive Sleep Apnea
• Not have a diagnosis of Obstructive Sleep Apnea in the past 2 years

 

Time requirement

• Initial baseline appointment: assessments and questionnaires (related to cognition, sleep, function, mood and behavior) and sleep study assessment (at home or in-hospital)
• 6-month follow-up assessments and questionnaires (related to cognition, sleep, function, mood and behavior)
• 12-month follow-up phone call

 

TDRA Study Investigators

Dr. Mark Boulos

 

More information

https://ifpoc.org/project/enhancing-outcomes-in-cognitive-impairment-through-use-of-home-sleep-apnea-testing-a-randomized-controlled-trial-enchant-study/

TDRA Site:

Sunnybrook Health Sciences Centre

Address: 2075 Bayview Ave, Toronto, ON M4N 3M5

Age Group:

50 - 54, 55 - 59, 60 - 64, 65 - 69, 70 - 80, 81 - 85, 86 - 90, 91+

Target Population:

Alzheimer’s disease, Dementia with Lewy bodies (DLB), Mild cognitive impairment, Parkinson's disease dementia, Parkinson's disease-related dementia, Vascular dementia